Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

George Wahba Master's Scholarship: The Cellular and Molecular Basis for Gastrointestinal Dysmotility in Rett Syndrome

EF 2013-14

Résumé
Rett Syndrome is a developmental disorder that affects 1 in 10 000 girls. It is characterized by normal development until 6-18 months preceding the onset of symptoms which include motor difficulties, developmental delay and seizures. Most cases of Rett Syndrome are caused by a mutation in the mecp2 gene, which codes for the MeCP2 protein, which has an important role in brain development. For instance, it has been well established that absence of proper MeCP2 function renders brain neurons incapable of properly undergoing “synaptic plasticity”. Synaptic plasticity is the process by which neurons adjust how strongly they communicate with one another and is the fundamental mechanism by which our brain learns, develops and matures. Recent clinical reports disclose that Rett patients also suffer from severe gastrointestinal dysmotility. The gastrointestinal tract can be a modeled as a tube with multiple layers. One of the layers, the “enteric nervous system,” is composed of “enteric” neurons which control the activities of the tract such as its motility. Fortunately, however, in both the brain and the enteric nervous system, there is no sign of major neuron death which raises the possibility of reversal of symptoms in Rett Syndrome patients. As a result, my hypothesis is that, as in the brain, MeCP2 mutation causes enteric neurons to be unable to undergo proper synaptic plasticity. As a result, enteric neurons do not work properly and they lose proper control of the gastrointestinal tract leading to the observed symptoms seen in Rett Syndrome patients. My project will thus focus on studying in depth the plasticity of enteric neurons and attempting to relieve the gastrointestinal dysmotility seen in Rett Syndrome patients. First enteric neurons will be dissociated from the gastrointestinal system of normal mice. Along with colleagues, I have developed a quick and efficient method to dissociate these neurons and grow them. These neurons will then be used to study their plasticity and the mechanisms underlying it. Enteric neurons will also be dissociated from the gastrointestinal system of mice with a mecp2 mutation (these mice closely resemble human Rett Syndrome patients and serve as a reliable model for the disease), which are commercially available. These neurons will serve to diagnose if there is a deficit in plasticity in Rett Syndrome and if so, which mechanisms are behind this deficiency. The last part of my project will take a more therapeutic approach; I will then attempt to identify pharmacological interventions which can restore proper synaptic plasticity in enteric neurons from mice with a mecp2 mutation and restore normal gastrointestinal motility. There are three purposes for my project. First, very little is known about synaptic plasticity in enteric neurons. As a result, this project will not only greatly contribute to the treatment of Rett Syndrome but to the multitude of other diseases which have a neuro-gastrointestinal component. Second, this study will hopefully lead to the identification of an agent capable of relieving the gastrointestinal dysmotility seen in Rett Syndrome patients which will improve their quality of life. Finally, my project will also serve as a model to treat the brain eventually. The enteric nervous system has neurons that function similarly to those of the brain but unlike the brain, it does not feature the barriers that make the brain so inaccessible to pharmacological agents. Thus, the enteric nervous system can serve as a quick and representative model to eventually treat brain symptoms in Rett Syndrome, which while rare, presents the unique prospect of reversibility.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311965
Name
Wahba George
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
George Wahba Master's Scholarship: The Cellular and Molecular Basis for Gastrointestinal Dysmotility in Rett Syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Enteric; Gastrointestinal; In Vitro; In Vivo; Plasticity; Rett Syndrome; Synaptic Scaling
Abstract
Rett Syndrome is a developmental disorder that affects 1 in 10 000 girls. It is characterized by normal development until 6-18 months preceding the onset of symptoms which include motor difficulties, developmental delay and seizures. Most cases of Rett Syndrome are caused by a mutation in the mecp2 gene, which codes for the MeCP2 protein, which has an important role in brain development. For instance, it has been well established that absence of proper MeCP2 function renders brain neurons incapable of properly undergoing “synaptic plasticity”. Synaptic plasticity is the process by which neurons adjust how strongly they communicate with one another and is the fundamental mechanism by which our brain learns, develops and matures. Recent clinical reports disclose that Rett patients also suffer from severe gastrointestinal dysmotility. The gastrointestinal tract can be a modeled as a tube with multiple layers. One of the layers, the “enteric nervous system,” is composed of “enteric” neurons which control the activities of the tract such as its motility. Fortunately, however, in both the brain and the enteric nervous system, there is no sign of major neuron death which raises the possibility of reversal of symptoms in Rett Syndrome patients. As a result, my hypothesis is that, as in the brain, MeCP2 mutation causes enteric neurons to be unable to undergo proper synaptic plasticity. As a result, enteric neurons do not work properly and they lose proper control of the gastrointestinal tract leading to the observed symptoms seen in Rett Syndrome patients. My project will thus focus on studying in depth the plasticity of enteric neurons and attempting to relieve the gastrointestinal dysmotility seen in Rett Syndrome patients. First enteric neurons will be dissociated from the gastrointestinal system of normal mice. Along with colleagues, I have developed a quick and efficient method to dissociate these neurons and grow them. These neurons will then be used to study their plasticity and the mechanisms underlying it. Enteric neurons will also be dissociated from the gastrointestinal system of mice with a mecp2 mutation (these mice closely resemble human Rett Syndrome patients and serve as a reliable model for the disease), which are commercially available. These neurons will serve to diagnose if there is a deficit in plasticity in Rett Syndrome and if so, which mechanisms are behind this deficiency. The last part of my project will take a more therapeutic approach; I will then attempt to identify pharmacological interventions which can restore proper synaptic plasticity in enteric neurons from mice with a mecp2 mutation and restore normal gastrointestinal motility. There are three purposes for my project. First, very little is known about synaptic plasticity in enteric neurons. As a result, this project will not only greatly contribute to the treatment of Rett Syndrome but to the multitude of other diseases which have a neuro-gastrointestinal component. Second, this study will hopefully lead to the identification of an agent capable of relieving the gastrointestinal dysmotility seen in Rett Syndrome patients which will improve their quality of life. Finally, my project will also serve as a model to treat the brain eventually. The enteric nervous system has neurons that function similarly to those of the brain but unlike the brain, it does not feature the barriers that make the brain so inaccessible to pharmacological agents. Thus, the enteric nervous system can serve as a quick and representative model to eventually treat brain symptoms in Rett Syndrome, which while rare, presents the unique prospect of reversibility.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wahba, George
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~